Page last updated: 2024-08-23

bm 13505 and Coronary Disease

bm 13505 has been researched along with Coronary Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, A; Karasawa, A; Kawakage, M; Kubo, K; Miki, I; Shirakura, S; Takeda, M1
Lefer, AM1
Earl, CQ; Egan, JW; Griswold, DE; Hillegass, LM; Marshall, PJ; Smith, EF1
Bhat, AM; Lefer, AM; Osborne, JA; Sacks, H1
Lefer, AM; Osborne, JA1
Ney, P; Schrör, K; Thiemermann, C1
Farber, NE; Gross, GJ; Pieper, GM1

Other Studies

7 other study(ies) available for bm 13505 and Coronary Disease

ArticleYear
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
    Arzneimittel-Forschung, 1991, Volume: 41, Issue:12

    Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygenase Inhibitors; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Nifedipine; Phenylacetates; Propranolol; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Ticlopidine

1991
Role of thromboxane A2 in myocardial ischemia and circulatory shock.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1989, Volume: 19

    Topics: Animals; Cats; Coronary Disease; Myocardial Reperfusion Injury; Phenylacetates; Platelet Aggregation; Rabbits; Shock; Sulfonamides; Thromboxane A2; Thromboxanes

1989
Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
    Progress in clinical and biological research, 1989, Volume: 301

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Coronary Disease; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Phenylacetates; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Inbred Strains; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides

1989
Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
    American heart journal, 1989, Volume: 117, Issue:4

    Topics: Acute Disease; Animals; Blood Pressure; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Heart Rate; Male; Myocardial Reperfusion Injury; Myocardium; Necrosis; Phenylacetates; Sulfonamides; Thromboxanes

1989
Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits.
    The American journal of physiology, 1988, Volume: 255, Issue:2 Pt 2

    Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Coronary Disease; Coronary Vessels; Creatine Kinase; Male; Phenylacetates; Rabbits; Receptors, Prostaglandin; Receptors, Thromboxane; Reference Values; Sulfonamides; Thromboxanes

1988
The thromboxane receptor antagonist, daltroban, protects the myocardium from ischaemic injury resulting in suppression of leukocytosis.
    European journal of pharmacology, 1988, Oct-11, Volume: 155, Issue:1-2

    Topics: Adenosine Triphosphate; Animals; Cats; Coronary Disease; Creatine Kinase; Electrocardiography; Female; Heart Rate; Hemodynamics; Leukocytosis; Male; Myocardial Contraction; Myocardium; Neutrophils; Oxygen; Phenylacetates; Platelet Count; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboxanes

1988
Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
    Circulation, 1988, Volume: 78, Issue:2

    Topics: Animals; Coronary Circulation; Coronary Disease; Dogs; Energy Metabolism; Female; Heart; Hemodynamics; Imidazoles; Male; Myocardial Contraction; Phenylacetates; Phosphates; Prostaglandins; Sulfonamides; Thromboxane A2; Thromboxane-A Synthase

1988